many pharmaceutical firms and labs around the world worked nonstop to come up with the 'magic' vaccine that would keep people from being infected by the corona virus. More importantly for this class, they were also racing to be the first to market, or, using strategic management terminology, they were trying hard to be the 'first mover'. In this particular Covid-19 context, did being the first to market (or the first mover)matter to all these firms pursuing an innovation strategy the way it usually does in a "normal" environment? What made the 'first mover' game for all these firms different from, for example, Samsung introducing the smart watch way ahead of its potential competitors